Abstract:Abstract Background Agitation is common in subarachnoid hemorrhage (SAH), and sedation with midazolam, propofol and dexmedetomidine is essential in agitation management. Previous research shows the tendency of dexmedetomidine and propofol in improving long-term outcome of SAH patients, whereas midazolam might be detrimental. Brain metabolism derangement after SAH might be interfered by sedatives. However, how sedatives work and whether the drugs interfere with patient outcome by altering cerebral metabolism is unclear, and the comprehensive view of how sedatives regulate brain metabolism remains to be elucidated. Methods For cerebrospinal fluid (CSF) and extracellular space of the brain exchange instantly, we performed a cohort study, applying CSF of SAH patients utilizing different sedatives or no sedation to metabolomics. Baseline CSF metabolome was corrected by selecting patients of the same SAH and agitation severity. CSF components were analyzed to identify the most affected metabolic pathways and sensitive biomarkers of each sedative. Markers might represent the outcome of the patients were also investigated. Results Pentose phosphate pathway was the most significantly interfered (upregulated) pathway in midazolam ( p = 0.0000107, impact = 0.35348) and propofol ( p = 0.00000000000746, impact = 0.41604) groups. On the contrary, dexmedetomidine decreased levels of sedoheptulose 7-phosphate ( p = 0.002) and NADP ( p = 0.024), and NADP is the key metabolite and regulator in pentose phosphate pathway. Midazolam additionally augmented purine synthesis ( p = 0.00175, impact = 0.13481) and propofol enhanced pyrimidine synthesis ( p = 0.000203, impact = 0.20046), whereas dexmedetomidine weakened pyrimidine synthesis ( p = 0.000000000594, impact = 0.24922). Reduced guanosine diphosphate (AUC of ROC 0.857, 95%CI 0.617–1, p = 0.00506) was the significant CSF biomarker for midazolam, and uridine diphosphate glucose (AUC of ROC 0.877, 95%CI 0.631–1, p = 0.00980) for propofol, and succinyl-CoA (AUC of ROC 0.923, 95%CI 0.785–1, p = 0.000810) plus adenosine triphosphate (AUC of ROC 0.908, 95%CI 0.6921, p = 0.00315) for dexmedetomidine. Down-regulated CSF succinyl-CoA was also associated with favorable outcome (AUC of ROC 0.708, 95% CI: 0.524–0.865, p = 0.029333). Conclusion Pentose phosphate pathway was a crucial target for sedatives which alter brain metabolism. Midazolam and propofol enhanced the pentose phosphate pathway and nucleotide synthesis in poor-grade SAH patients, as presented in the CSF. The situation of dexmedetomidine was the opposite. The divergent modulation of cerebral metabolism might further explain sedative pharmacology and how sedatives affect the outcome of SAH patients.

Influence of Caffeine on the Sedative Effects of Promethazine Based on Pharmacokinetics and Metabolomics

An HPLC-ESI-MS method for simultaneous determination of fourteen metabolites of promethazine and caffeine and its application to pharmacokinetic study of the combination therapy against motion sickness.

Alteration of intracerebral metabolites and subjective sleepiness by acute caffeine administration in adults

The Hypnotic Synergism among a Water-Soluble Prodrug of Propofol,Midazolam and Fentanyl

Simulated pharmacokinetics of inhaled caffeine and melatonin from existing products indicate the lack of dosimetric considerations

Caffeine and modafinil modulate the effects of sleep deprivation on thalamic resting-state functional connectivity: A double-blind pilot study

Two combined amino acids promote sleep activity in caffeine-induced sleepless model systems

A Multifunctional Efficacious Molecule with Diverse Health Implications and Emerging Delivery Systems

Network Pharmacology Analysis of the Potential Pharmacological Mechanism of a Sleep Cocktail

Pharmacological Modulation of Sleep Homeostasis in Rat: Novel Effects of an mGluR2/3 Antagonist

Comprehensive quantitative method for neurotransmitters to study the activity of a sedative-hypnotic candidate using microdialysis and LC×LC-MS/MS

Chronic administration of caffeine, modafinil, AVL-3288 and CX516 induces time-dependent complex effects on cognition and mood in an animal model of sleep deprivation

Ambient mass spectrometry imaging metabolomics method provides novel insights into the action mechanism of drug candidates.

A combined effect of fish-originated collagen peptides and caffeine on the cognitive function of sleep-deprived mice.

Noradrenergic Modulation of Stopping Impulsivity in Cocaine Use Disorder

Cerebrospinal fluid metabolic profiling reveals divergent modulation of pentose phosphate pathway by midazolam, propofol and dexmedetomidine in patients with subarachnoid hemorrhage: a cohort study

Caffeine-related effects on cognitive performance: Roles of apoptosis in rat hippocampus following sleep deprivation

Combination administration of alprazolam and N-Ethylmaleimide synergistically enhances sleep behaviors in mice with no potential CNS side effects

The mechanism of simultaneous intake of Jujuboside A and B in the regulation of sleep at the hypothalamic level

Interindividual Differences in Caffeine Metabolism and Factors Driving Caffeine Consumption

Dynamical changes of interaction across functional brain communities during propofol-induced sedation